Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer DOI

Xiang Gong,

Chao Zheng, Ying Cai

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 367, P. 637 - 648

Published: Feb. 8, 2024

Language: Английский

A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy DOI
Yuan Chen,

Zhuo Yao,

Peilian Liu

et al.

Acta Biomaterialia, Journal Year: 2023, Volume and Issue: 159, P. 275 - 288

Published: Jan. 26, 2023

Language: Английский

Citations

48

Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy DOI
Chong Wang, Qiang Wang, Huimin Wang

et al.

Journal of Controlled Release, Journal Year: 2022, Volume and Issue: 353, P. 391 - 410

Published: Dec. 6, 2022

Language: Английский

Citations

52

Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy DOI Creative Commons
Qiaolin Liu, Yuliang Zhao, Huige Zhou

et al.

Regenerative Biomaterials, Journal Year: 2023, Volume and Issue: 10

Published: Jan. 1, 2023

Abstract Ferroptosis, a completely new form of regulated cell death, is mainly caused by an imbalance between oxidative damage and reductive protection has shown great anti-cancer potential. However, existing small-molecule ferroptosis inducers have various limitations, such as poor water solubility, drug resistance low targeting ability, hindering their clinical applications. Nanotechnology provides opportunities for ferroptosis-driven tumor therapy. Especially, stimuli-responsive nanomaterials stand out among others been widely researched because unique spatiotemporal control advantages. Therefore, it’s necessary to summarize the application those in ferroptosis. Here, we describe physiological feature illustrate current challenges induce cancer Then, that are classified elaborated according external internal stimuli. Finally, future perspectives field proposed. We hope this review facilitates paving way design intelligent nano-ferroptosis inducers.

Language: Английский

Citations

42

Application of molecular dynamics simulation in self-assembled cancer nanomedicine DOI Creative Commons

Xueli Xu,

Ao Liu, Shuangqing Liu

et al.

Biomaterials Research, Journal Year: 2023, Volume and Issue: 27(1)

Published: Feb. 9, 2023

Self-assembled nanomedicine holds great potential in cancer theragnostic. The structures and dynamics of can be affected by a variety non-covalent interactions, so it is essential to ensure the self-assembly process at atomic level. Molecular (MD) simulation key technology link microcosm macroscale. Along with rapid development computational power methods, scientists could simulate specific intermolecular interactions. Thus, some experimental observations explained microscopic level synthesis would have traces follow. This review not only outlines concept, basic principle, parameter setting MD simulation, but also highlights recent progress for self-assembled nanomedicine. In addition, physicochemical parameters structure interaction between various assembled molecules under are discussed. Therefore, this will help advanced novice researchers quickly zoom on fundamental information gather thought-provoking ideas advance subfield

Language: Английский

Citations

32

Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics DOI Creative Commons

Qing Pei,

Bowen Jiang,

Dengyuan Hao

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2023, Volume and Issue: 13(8), P. 3252 - 3276

Published: March 5, 2023

Chemotherapy has occupied the critical position in cancer therapy, especially towards post-operative, advanced, recurrent, and metastatic tumors. Paclitaxel (PTX)-based formulations have been widely used clinical practice, while therapeutic effect is far from satisfied due to off-target toxicity drug resistance. The caseless multi-components make preparation technology complicated aggravate concerns with excipients-associated toxicity. self-assembled PTX nanoparticles possess a high content could incorporate various functional molecules for enhancing index. In this work, we summarize self-assembly strategy diverse nanodrugs of PTX. Then, advancement tumor emphasis on mono-chemotherapy, combinational theranostics, outlined. Finally, challenges potential improvements briefly spotlighted.

Language: Английский

Citations

29

Structure–Activity Relationship of pH-Sensitive Doxorubicin-Fatty Acid Prodrug Albumin Nanoparticles DOI
Yinxian Yang, Xiuhong Li,

Jiaxuan Song

et al.

Nano Letters, Journal Year: 2023, Volume and Issue: 23(4), P. 1530 - 1538

Published: Jan. 31, 2023

Albumin has emerged as a versatile drug carrier. To harness albumin carrier for doxorubicin (DOX), we synthesized three acid-labile DOX prodrugs using stearic acid (SA), oleic (OA), and linoleic (LA) the albumin-binding motif, respectively. Different from conventional nanodrugs (such Abraxane, with loading of 10%), assembled nanoparticles (NPs) have an ultrahigh (>35%). Noteworthy, demonstrated that saturation fatty acids exerted great influence on colloidal stability prodrug NPs, thus affecting their in vivo pharmacokinetics, tumor accumulation antitumor efficacy. Furthermore, hydrazone bond-bridged could remain intact bloodstream but allow to be released acidic environment, resulting improved efficacy safety. Our work gives novel insights into structure-to-efficacy relationship albumin-bound provides simple strategy advanced nanomedicines.

Language: Английский

Citations

26

Disturbing cytoskeleton by engineered nanomaterials for enhanced cancer therapeutics DOI Creative Commons

Xueli Xu,

Shanbin Xu,

Jipeng Wan

et al.

Bioactive Materials, Journal Year: 2023, Volume and Issue: 29, P. 50 - 71

Published: June 29, 2023

Cytoskeleton plays a significant role in the shape change, migration, movement, adhesion, cytokinesis, and phagocytosis of tumor cells. In clinical practice, some anti-cancer drugs achieve cytoskeletal therapeutic effects by acting on different protein components. However, absence cell-specific targeting, unnecessary recombination organisms would be disastrous, which also bring about severe side during anticancer process. Nanomedicine have been proven to superior small molecule cancer treatment due better stability lower effects. Therefore, this review summarized recent developments various nanomaterials disturbing cytoskeleton for enhanced therapeutics, including carbon, noble metals, metal oxides, black phosphorus, calcium, silicon, polymers, peptides, metal-organic frameworks, etc. A comprehensive analysis characteristics therapy as well future prospects challenges towards application were discussed. We aim drive emerging topic through refreshing perspectives based our own work what we learnt from others. This will help researchers quickly understand relevant information further advance development nanomedicine.

Language: Английский

Citations

26

Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review DOI Creative Commons
Xuan Meng,

Yongli Shen,

Huanyu Zhao

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Sept. 28, 2024

Language: Английский

Citations

17

Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassemblies DOI Creative Commons
Shiyi Zuo, Tian Liu, Lingxiao Li

et al.

Cell Reports Medicine, Journal Year: 2024, Volume and Issue: 5(3), P. 101432 - 101432

Published: Feb. 21, 2024

Dimeric prodrug nanoassemblies (DPNAs) stand out as promising strategies for improving the efficiency and safety of chemotherapeutic drugs. The success trisulfide bonds (-SSS-) in DPNAs makes polysulfide a worthwhile focus. Here, we explore comprehensive role tetrasulfide (-SSSS-) constructing superior DPNAs. Compared to disulfide bonds, endow with superlative self-assembly stability, prolonged blood circulation, high tumor accumulation. Notably, ultra-high reduction responsivity make highly selective "tumor bomb" that can be ignited by endogenous reducing agents cells. Furthermore, present an "add fuel flames" strategy intensify reductive stress at sites replenishing exogenous agents, making considerable progress inhibition. This work elucidates crucial establishing intelligent DPNAs, alongside combination methodology, propelling new heights potent cancer therapy.

Language: Английский

Citations

16

Activated aggregation‐induced emission therapeutics agents for triggering regulated cell death DOI Creative Commons

Yu‐Qiang Zhao,

Le Yu,

Lanyun Zhang

et al.

Aggregate, Journal Year: 2024, Volume and Issue: 5(3)

Published: Jan. 22, 2024

Abstract The induction of regulated cell death (RCD) through photo/ultrasound sensitization therapeutic agents has gained significant attention as a vital approach to combat drug resistance in tumors. Aggregation‐induced emission (AIE) generate reactive oxygen species activation, which can synergize with RCD inducers or directly induce RCD, ultimately resulting the tumor cells. presented comprehensive review delves into recent advancements AIE designed trigger inducers, encompassing apoptosis, necroptosis, pyroptosis, immunogenic death, autophagy, ferroptosis, and cuproptosis. Additionally, intricate regulatory mechanisms activatory‐AIE therapeutics influence distinct pathways are examined. A forward‐looking perspective on future developments pertinent challenges within this exciting realm is presented, anticipating continued evolution activatable transformative enhance therapy.

Language: Английский

Citations

14